Product Information
CONJUGATED ESTROGENS 0.45 MG TB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $5.4808 per EA under NDC 50742038801. Its NADAC has been published 33 times since Feb 18, 2026.
FDA first approved this application on Oct 15, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.45 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742038801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESTROGENS, CONJUGATEDApproval Type
Generic (ANDA)
FDA Application
ANDA214025FDA Approved
10/15/2025
TE Code
AB
On Market Since
10/16/2025
Pharmacological Classes
Price Statistics
The NADAC for CONJUGATED ESTROGENS 0.45 MG TB has been published 33 times since Feb 18, 2026, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4808 per EA |
|---|---|
| All-time high | $5.9705 (Mar 11, 2026) |
| All-time low | $5.4808 (Sep 23, 2026) |
| 52-week high | $5.9705 |
| 52-week low | $5.4808 |
| Median price | $5.9012 |
| Average price | $5.8384 |
| Largest weekly change | -2.9% (Sep 23, 2026) |
| Weeks tracked | 33 |
| Tracking since | Feb 18, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
estrogens, conjugated market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CONJUGATED ESTROGENS 0.45 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for CONJUGATED ESTROGENS 0.45 MG TB, manufactured by Ingenus Pharmaceuticals LLC, is $5.4808 per EA (NDC 50742038801), effective Sep 30, 2026.
How has the price of CONJUGATED ESTROGENS 0.45 MG TB changed over time?
Over the history we have for it, the NADAC for CONJUGATED ESTROGENS 0.45 MG TB has declined 8.2%. It has been tracked across 33 weekly CMS publications since Feb 18, 2026.
What are the highest and lowest recorded NADAC prices for CONJUGATED ESTROGENS 0.45 MG TB?
Since Feb 18, 2026, the NADAC for CONJUGATED ESTROGENS 0.45 MG TB has ranged from a low of $5.4808 (Sep 23, 2026) to a high of $5.9705 (Mar 11, 2026), with a median of $5.9012 per EA.
Are there cheaper alternatives to CONJUGATED ESTROGENS 0.45 MG TB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CONJUGATED ESTROGENS 0.45 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures CONJUGATED ESTROGENS 0.45 MG TB?
CONJUGATED ESTROGENS 0.45 MG TB (NDC 50742038801) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.